Transforming growth factor-β-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic

Supriya D Deshpande1, Sumanth Putta, Mei Wang

  • 1Irell & Manella Graduate School of Biological Sciences, Beckman Research Institute of the City of Hope, Duarte, California, USA.

Diabetes
|May 8, 2013
PubMed

Insights

Transforming growth factor-β1 (TGF-β) induces a feedback loop between p53 and microRNA-192 (miR-192), driving diabetic nephropathy (DN) progression. Inhibiting miR-192 or its genetic deletion protects against DN.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Genetics

Background:

  • Diabetic nephropathy (DN) is a complication of diabetes, characterized by kidney damage.
  • Elevated p53 expression is linked to kidney diseases, but its role in DN pathogenesis is not fully understood.
  • Transforming growth factor-β1 (TGF-β) and microRNA-192 (miR-192) are implicated in kidney fibrosis.

Purpose of the Study:

  • To elucidate the mechanisms linking p53, TGF-β, and miR-192 in diabetic nephropathy.
  • To investigate the therapeutic potential of targeting the miR-192/p53 axis in DN.

Main Methods:

  • Analysis of p53, TGF-β, and miR-192 expression in renal cortex of diabetic and control mice.
  • In vivo inhibition of miR-192 using locked nucleic acid-modified inhibitors.
  • Generation and study of miR-192 knockout mice subjected to diabetes induction.
  • In vitro promoter assays to determine regulatory relationships.
  • Correlation analysis of miR-192 and Zeb2 in human DN glomeruli.

Main Results:

  • Diabetic mice exhibited increased renal TGF-β, p53, and miR-192 expression, correlating with glomerular fibrosis.
  • miR-192 inhibition reduced p53 expression in diabetic mice.
  • miR-192 knockout mice showed attenuated TGF-β and p53 levels, with reduced DN features (fibrosis, hypertrophy, proteinuria).
  • TGF-β induced a feedback loop between miR-192 and p53 via Zeb2, promoting DN.
  • Inverse correlation between miR-192 and Zeb2 observed in human DN samples.

Conclusions:

  • A novel TGF-β-induced feedback loop between p53 and miR-192 contributes to DN pathogenesis.
  • Targeting miR-192 offers a potential therapeutic strategy for diabetic nephropathy.
  • miR-192 deficiency protects against key pathological features of diabetic nephropathy.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...